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Abstract
Background: There is a limited capacity to repair damage in the mammalian heart after birth, which is primarily
due to the inability of cardiomyocytes to proliferate after birth. This is in contrast to zebrafish and salamander, in
which cardiomyocytes retain the ability to proliferate throughout life and can regenerate their heart after significant
damage. Recent studies in zebrafish and rodents implicate microRNA (miRNA) in the regulation of genes responsible
for cardiac cell cycle progression and regeneration, in particular, miR-133a, the miR-15 family, miR-199a and miR-590.
However, the significance of these miRNA and miRNA in general in the regulation of cardiomyocyte proliferation in
large mammals, including humans, where the timing of heart development relative to birth is very different than in
rodents, is unclear. To determine the involvement of miRNA in the down-regulation of cardiomyocyte proliferation
occurring before birth in large mammals, we investigated miRNA and target gene expression in sheep hearts before
and after birth. The experimental approach included targeted transcriptional profiling of miRNA and target mRNA
previously identified in rodent studies as well as genome-wide miRNA profiling using microarrays.
Results: The cardiac expression of miR-133a increased and its target gene IGF1R decreased with increasing age,
reaching their respective maximum and minimum abundance when the majority of ovine cardiomyocytes were
quiescent. The expression of the miR-15 family members was variable with age, however, four of their target genes
decreased with age. These latter profiles are inconsistent with the direct involvement of this family of miRNA in
cardiomyocyte quiescence in late gestation sheep. The expression patterns of ‘pro-proliferative’ miR-199a and
miR-590 were also inconsistent with their involvement in cardiomyocyte quiescence. Consequently, miRNA microarray
analysis was undertaken, which identified six discrete clusters of miRNA with characteristic developmental profiles. The
functions of predicted target genes for the miRNA in four of the six clusters were enriched for aspects of cell division
and regulation of cell proliferation suggesting a potential role of these miRNA in regulating cardiomyocyte proliferation.
Conclusion: The results of this study show that the expression of miR-133a and one of its target genes is consistent
with it being involved in the suppression of cardiomyocyte proliferation, which occurs across the last third of
gestation in sheep. The expression patterns of the miR-15 family, miR-199a and miR-590 were inconsistent with
direct involvement in the regulation cardiomyocyte proliferation in sheep, despite studies in rodents demonstrating
that their manipulation can influence the degree of cardiomyocyte proliferation. miRNA microarray analysis suggests a
coordinated and potentially more complex role of multiple miRNA in the regulation of cardiomyocyte quiescence and
highlights significant differences between species that may reflect their substantial differences in the timing of this
developmental process.
Keywords: Microarray, miR-133, miR-15 family, miR-590, miR-199a, Cardiomyocyte, Proliferation
* Correspondence: janna.morrison@unisa.edu.au
1Early Origins of Adult Health Research Group, University of South Australia,
Adelaide, SA, Australia
Full list of author information is available at the end of the article
© 2015 Morrison et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Morrison et al. BMC Genomics  (2015) 16:541 
DOI 10.1186/s12864-015-1693-z
Background
From late gestation, the majority of human cardiomyo-
cytes cease proliferating due to either an absence of
karyokinesis and/or cytokinesis [1–3]. Consequently, and
in contrast to the neonatal mammalian heart, the adult
heart has limited capacity to regenerate cardiomyocytes
that may be lost due to damage or aging [4–6]. This is
dissimilar to zebrafish, whose cardiomyocytes retain the
ability to proliferate throughout life and are therefore
able to regenerate the heart after significant damage [7, 8].
The majority of regenerated zebrafish and neonatal mouse
cardiomyocytes originate from existing cardiomyocytes
rather than cardiac stem cells [4, 9–12] and are less differ-
entiated and have less contractile organisation compared
to those from un-injured myocardium [4, 9]. Recent evi-
dence suggests that microRNA (miRNA) regulate cardio-
myocyte proliferation and can induce reversion of adult
cardiomyocytes to a pro-proliferative state [13].
miRNA are small (~22 nucleotide) non-coding RNAs
that are often evolutionarily conserved between species.
miRNA originate from longer gene transcripts that form
hairpin loops, which are cleaved by the RNAase enzymes,
Drosher and Dicer, to generate mature miRNA. Once
bound to the Argonaut protein, miRNA guide the RNA-
induced silencing complex (RISC), sometimes referred
to as miRNP (miRNA-ribonucleoprotein complex), to
mRNA targets and subsequently regulate the expression
of genes by suppressing translation and/or initiating the
degradation of the mRNA. There are in excess of a
thousand miRNA encoded by the human genome and
each miRNA can inhibit multiple genes, thereby poten-
tially allowing the regulation of functional or develop-
mental pathways (for review see [14]).
A comparison of miRNA expression in regenerated
versus un-injured zebrafish myocardium identified miR-
133 as being specifically down-regulated during the
period of cardiomyocyte proliferation and regeneration
[7]. There are three genomic loci producing miR-133
with only miR-133a-1 and miR-133a-2 being expressed
in the heart [15]. miR-133 is one of the most abundant
cardiac miRNA [16] and is essential for normal cardio-
genesis in mice, through regulation of serum response
factor (SRF) [GenBank: NM_020493] dependent tran-
scription [17]. Interestingly, SRF together with Cyclin D2
(CCND2) [GenBank: NM_009829] was associated with
increased cardiomyocyte proliferation in miR-133a-1/
miR-133a-2 double-knockout mice [17]. miR-133a also
regulates Connexin-43 (GJA1) [GenBank: NM_131038]
[7], phosphoglycerate mutase (PGAM1) [GenBank:
NM_023418] [18] and connective tissue growth factor
(CTGF) [GenBank: NM_010217] [19–21] in regenerative
and proliferative cardiomyocytes. miR-133a has also
been implicated as an inhibitor of vascular smooth
muscle [22] and ovarian cancer [23] cell proliferation,
through the inhibition of insulin-like growth factor recep-
tor 1 (IGF-1R) [GenBank: NM_010513], which is a potent
stimulator of cardiomyocyte proliferation [24, 25].
Murine cardiomyocytes transition from a proliferative
to a quiescent state from days 4 to 10 after birth [26].
Comparisons of miRNA expression across this period
identified miR-195, a member of the miR-15 family, as
the most up-regulated miRNA and therefore possibly
implicated in the inhibition of cardiomyocyte prolifera-
tion [27]. Furthermore, across the period of diminished
proliferation in mice, the mRNA expression was reduced
for both conserved and non-conserved target genes of
the miR-15 family, such as Checkpoint kinase 1 (Chek1)
[GenBank: NM_007691], Cyclin dependent kinase-1
(Cdk1/Cdc2a) [GenBank: NM_007659], Survivin/Baculo-
viral inhibitor of apoptosis repeat-containing 5 (Birc5)
[GenBank: NM_001012273] and Sperm-associated antigen
5 (Spag5) [GenBank: NM_017407]. Furthermore, inhi-
biting the miR-15 family in vivo increased the number
of mitotic cardiomyocytes in mouse [12, 27].
Both miR-133a and the miR-15 family are associated
with inhibition of cardiomyocyte proliferation and myo-
cardial regeneration, however, there are also miRNA that
promote proliferation. miR-199a and miR-590 are in-
volved in promoting proliferation in rodents [13]. In
addition, treating adult rat cardiomyocytes with mimics
for miR-199a and miR-590 promotes cell cycle re-entry
and promotion of cardiac regeneration in vivo [13].
Using short interfering RNA that were specific for each
gene target of miR-199a and miR-590, the knockdown of
43 genes increased the percentage of cardiomyocytes
undergoing DNA synthesis by approximately 2-fold. Of
the genes that were associated with the up-regulation of
DNA synthesis, three genes (Chloride intracellular channel
protein 5 (Clic5) [GenBank: NM_172621], Homeodomain-
only protein (HopX) [GenBank: NM_001159900] and
Homer protein homolog 1 (Homer1) [GenBank: NM_
001284189]) were targets of both miR-199a and miR-590
and are therefore believed to be important regulators of
cell cycle activity in cardiomyocytes.
Mouse and rat cardiomyocytes become quiescent in
postnatal life and this process is complete by day 10 [26]
and 12 [28], respectively. The timing of quiescence in
rodents corresponds to a period just after birth when
there is significant cardiac remodelling triggered by
changes in the circulation due to air breathing and the
switch in cardiomyocyte metabolism from predomin-
antly glycolysis in utero to fatty acid oxidation in postna-
tal life [29]. Hence, changes in miRNA and target gene
expression during this period in rodents are difficult to
interpret due to metabolic changes occurring with devel-
opmental processes. Quiescent human cardiomyocytes
have been identified from as early as 0.8 of gestation
[30] and the process is generally near complete by birth,
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however, recent studies demonstrate that a very low level
cardiomyocyte proliferation may extend to 20 years
of age [31]. The in utero transition to quiescence in
humans is similarly timed to sheep, a species where
cardiomyocytes become quiescent due to binucleation
from 0.75 of gestation [32] and the percentage of cardio-
myocytes in the cell cycle decreases from 7 % at 110 days
gestation to 1 % close to birth [33]. The current investi-
gation aimed to gain greater insight into the regulation
of human cardiomyocyte proliferation by determining
the expression of specific miRNA and their target genes,
from the aforementioned zebrafish and murine studies,
in sheep myocardium across late gestation and early
postnatal life. Through the use of a miRNA microarray,
we further aimed to determine the expression of all
miRNA across this developmental window, thereby iso-
lating the miRNA that may regulate cardiomyocyte
quiescence from those associated with the major physio-
logical and biochemical changes that occur just after
birth.
Results
Body and heart weight measurements
Body weight and heart weight data were collected at
each time point and, as expected, increased with age
(P < 0.05; Table 1). Heart and body growth patterns were
in unison until 5 days of age, such that heart weight rela-
tive to body weight was maintained, however, at 21 days
of age and furthermore at 173 days of age, heart weight
relative to body weight decreased (P < 0.05).
Expression of miRNA involved in regulation of cardiac
proliferation and their target genes
Two complementary experimental strategies were used to
profile ovine miRNA and their target genes over the
cardiac developmental period from 91 days of gestation to
173 days of age. First, qRT-PCR was used to measure the
expression of specific ovine miRNA and target genes asso-
ciated with rodent and zebrafish cardiomyocyte quiescence.
Second, for comprehensive analysis a miRNA microarray
was used to profile over 3000 probes representing miRNA
from several mammalian species, including sheep and a
bioinformatics approach was undertaken to predict
enriched functions associated with clusters of develop-
mentally regulated miRNA.
Developmental profiling of rodent and zebrafish miRNA
by qRT-PCR
The ovine cardiac expression of three sets of miRNA,
which are highly conserved across species, and their
target genes that were previously associated with regu-
lation of cardiomyocyte proliferation in rodent and
zebrafish [7, 12, 13] were measured by qRT-PCR at each
developmental age to investigate their roles in prenatal car-
diomyocyte quiescence in a larger mammal, sheep, charac-
terised by quiescence of cardiomyocytes in late gestation.
miR-133a
The expression of miR-133a increased with age and
reached its maximum expression by 5 days of age (P < 0.05;
Fig. 1a). Counterintuitively, the expression of the miR-
133a gene targets that promote cardiomyocyte prolifer-
ation in rodents, CCND2, SRF, PGAM1 and GJA1, had
their highest expression after birth (P < 0.05; Fig. 1b),
when the majority of sheep cardiomyocytes were binu-
cleated and quiescent. Furthermore, the expression of
miR-133a gene target CTFG did not change with age
(Fig. 1b). These results suggest that these genes are not dir-
ectly regulated by miR-133a in sheep or are subject to more
complex and overriding developmental regulators. The
result also indicates that these genes are unlikely to be
directly involved in ovine cardiomyocyte quiescence in
sheep. The increased expression of miR-133a, however,
coincided with decreased expression of IGF1R, a known
target for this miRNA [22, 23] (P < 0.05; Fig. 1c).
miR-15 family
The miR-15 family contains five miRNA, miR-15a, miR-
15b, miR-16, miR-195 and miR-497. Ovine cardiac ex-
pression of miR-15a expression was lowest at 140 days
gestation and highest at 21 days of age (P < 0.05), the
expression of miR-15b was lowest at 173 days of age and
highest at 5 days of age (P < 0.05) and miR-195 expres-
sion was lowest at 140 days gestation and highest at
91 days gestation, 5 and 21 days of age (P < 0.05). The
expression of both miR-16 and miR-497 did not change
with age (Fig. 2a). Despite the variable expression pat-
terns of members of the miR-15 family, the expression
of their target mRNAs (CHEK1, CDC2A, BIRC5 and
SPAG5) decreased with increasing age, reaching a
minimum and then plateauing at 140 days gestation
(P < 0.05; Fig. 2b). Given that these genes are involved in
cell cycle progression and mitosis [34–37], these results
suggest that the decreased expression of these genes
may be involved in ovine cardiomyocyte quiescence,
Table 1 Fetal body and heart weight measurements
Body weight (kg) Heart weight (g) Heart weight/Body
weight (g/kg)
F91 0.67 ± 0.02a 4.41 ± 0.86a 6.67 ± 1.32c
F120 2.38 ± 0.14a 17.42 ± 1.11a 7.36 ± 0.30c
F140 5.18 ± 0.17b 38.5 ± 2.25b 7.46 ± 0.51c
P5 5.46 ± 0.16b 43.47 ± 2.57b 7.93 ± 0.29c
P21 13.21 ± 0.31c 81.38 ± 3.26c 6.19 ± 0.33b
P173 42.39 ± 1.38d 196.09 ± 6.94d 4.63 ± 0.07a
F Fetal age, P Postnatal age in days; Values are mean ± SEM. Values with a
different letter signify that age points are significantly different from each
other. P <0.05 was considered significant
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Fig. 1 Expression of miR-133a and its target mRNAs during heart development. miR-133a increased with age (a) and the expression of its target
genes, PGAM1, GJA1, SRF and CCND2 increased between 5 and 21 days of age (b) and IGF1R decreases with age (c). Data are expressed relative to
91 days gestation. F Fetal, P Postnatal, d age in days, NS not significant. Values with a different letter signify that age points are significantly different
from each other. P <0.05 was considered significant
Fig. 2 Expression of miR-15 family members and their target mRNA during heart development. The expression of miR-15 family members is
variable with age (a), however, the expression of their target genes CHEK1, CDC2A, BIRC5 and SPAG5 decreased with age (b). Data are expressed relative
to 91 days gestation; F Fetal, P Postnatal, d age in days, NS not significant. Values with a different letter signify that age points are significantly different
from each other. P <0.05 was considered significant
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however, the miR-15 family may not be the principal de-
velopmental regulator of these genes or ovine cardio-
myocyte quiescence.
miR-199a and miR-590
The expression of miR-199a peaked around birth, but
then decreased by 21 days of age to the level seen at
91 days gestation (P < 0.05; Fig. 3a). The expression of
miR-590, however, did not change with age (Fig. 3a).
The expression of HOPX, a target of both miR-199a and
miR-590 [13], did not change with age (Fig. 2b), how-
ever, the expression of CLIC5 and HOMER1 increased
with age and reached their maximum expression by
5 days and 173 days of age, respectively (Fig. 2b). These
data suggest that miR-199a and miR-590 miRNA and
their target genes may not be directly involved in ovine
cardiomyocyte quiescence.
miRNA microarray analysis
The targeted profiling of miRNA identified in rodent
and zebrafish investigations showed limited correspond-
ence with the developmental program of ovine cardio-
myocyte quiescence occurring during late gestation in
sheep. Consequently, miRNA microarrays were used to
investigate age related changes in cardiac miRNA in a
subset of the animals (n = 3 at each of Fetal (F) 91, F140,
Postnatal (P) 5 and P173). This approach complements
the targeted miRNA approach and has the potential to
identify additional miRNA and possibly broader func-
tional themes associated with cardiac development in
sheep. A custom designed miRNA microarray that in-
corporated multiple replicates of 3,098 unique probes
for sheep and other mammalian miRNA was used.
Technical limitations of the approach are listed in the
Methods. A PCA analysis of the microarray data shows
separation of the four developmental groups and cluster-
ing of the biological replicates within these groups
(Fig. 4). The first component in the analysis explained
97 % of the variation. A total of 297 (9.6 %) differentially
expressed probes (FDR corrected P ≤ 0.05) were identi-
fied, which included 14 anonymous probes and some
redundant probes. The full analysis is presented in
Additional file 1. The analysis clearly indicates that
multiple miRNA are involved in cardiac development and
age related functions, and suggests substantial complexity
in the regulation of target gene expression orchestrating
these developmental and physiological changes.
k-means clustering of the differentially expressed miRNA
separated the developmental data into six discrete clusters
(Fig. 5). This analysis posits that miRNA within a cluster
have functions pertaining to the specific developmental
transition represented by the cluster profile. The largest
clusters were 2 and 4 containing 88 and 91 probes,
respectively (Additional file 1 and Table 2). The former
cluster represented a progressive decline in overall
signal with all developmental time points while the
latter cluster represented a progressive increase of sig-
nal with development. Clusters 1, 3 and 6 (35, 28 and 23
probes, respectively) showed more complex develop-
mental profiles that may reflect key developmental tran-
sitions in the myocardium and the indirect impacts of
the major physiological and biochemical changes occur-
ring after birth. In particular, these clusters are charac-
terised by major transitions between the late gestation
Fig. 3 Expression of pro-proliferative miR, mir-199a and miR-590, and their target mRNA during heart development. miR-199a increases with age,
but is then reduced to the level seen at 91 days gestation by 21 days of age (a). The expression of CLIC5 and HOMER1 is increased in postnatal life
(b). Data are expressed relative to 91 days gestation; F, Fetal; P, Postnatal; d, age in days. Values with a different letter signify that age points are
significantly different from each other. P <0.05 was considered significant
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fetus at 140 days gestation and the lamb at 5 days after
birth. Cluster 5 showed a profile characterised as a small
continuous decline until 5 days after birth followed by a
more substantial decline to 173 days after birth.
In general, the patterns of the miRNA measured by
qRT-PCR were consistent with the cluster profiles. miR-
133a was present in Cluster 4 and displayed the same
pattern of expression in both qRT-PCR and microarray
analysis. miR-15 family members miR-15b, miR-16, miR-
195 and miR-497 were identified in Clusters 5, 2, 1 and
4, respectively. miR-199a was identified in Cluster 2 and
the expression pattern of miR-590 did not allow its
inclusion in any cluster.
miRNA are often genomically positioned in groups on
chromosomes and we therefore investigated whether
any of the miRNA clusters were associated with specific
chromosomal regions. By mapping the miRNA to ovine
chromosomes (UCSC Genome Browser; OAR_c3.1
sheep assembly [38]), we determined that Cluster 5 was
strongly overrepresented by miRNA (83 % of all miRNA
Fig. 4 Principal Components Analysis of the miRNA microarray data. The data represented in a PCA plot show separation of the four developmental
age groups and clustering of the biological replicates within these groups. Red, Fetal 91 days gestation; Green, Fetal 140 days gestation; blue, Postnatal
5 days; yellow, Postnatal 173 days
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in Cluster 5) associated with a large and complex group
of miRNA in a 250 kb region located toward the telo-
meric end of OAR18 (Fig. 6). The broader 1.1 Mb re-
gion encompassing the protein encoding genes BEGAIN
to DIO3 is imprinted and the miRNA within this region
are maternally expressed [39–41]. The biological and
molecular roles of these miRNA are unclear.
To identify putative mRNA targets for the miRNA, a
non-redundant set of miRNA corresponding to each
k-means cluster (filtered for removal of low expression
Table 2 Summary of nonredundant miRNA present in each k-means cluster
Cluster number miRNAa
1 miR-29a-3p; miR-29b; miR-1-1-5p; miR-1-2-5p; miR-142-3p; miR-499b-3p; miR-101; mir-2284z-6-p3; miR-6412; mir-2284z-5-p5;
miR-499-5p; miR-499; miR-499b-5p; miR-1; miR-451; miR-126a-5p; miR-6119-5p; miR-10b; miR-1-5p; miR-195; miR-140-5p;
miR-29d-3p; miR-29a; miR-101c; miR-208b
2 mir-3431-p3; miR-433-3p; mir-3431-p3; mir-3431-p5; miR-503-5p; miR-324; miR-542-5p; miR-382-3p; miR-181a-2-3p; miR-3431;
miR-324-3p; miR-362-5p; miR-362; miR-181b-5p; miR-181b; miR-106b-3p; mir-181b-2-p3; miR-204; miR-199a-5p; miR-484;
miR-155; miR-20b; miR-1343-3p; miR-224; miR-132-3p; miR-106a; mir-99b-p5; miR-99b; miR-17-5p; miR-93; mir-466i-p5; miR-16a;
miR-16b; miR-16-5p
3 miR-2137; mir-1285-p5; mir-6323-p5; PC-5p-51320_64; miR-1973; mir-1973-p3; miR-4792; mir-4485-p5; mir-940-p5; miR-4448;
miR-671-5p; mir-2487-p5; miR-1835; mir-4419a-p5; mir-1246-p5; mir-218-1-p5; miR-122; mir-466b-2-p3; mir-378f-p5; mir-4426-p3
4 miR-145; miR-133b; miR-378; miR-133a; miR-378c; miR-378b; miR-133; miR-378d; miR-24; miR-24-3p; mir-7641-1-p5; miR-133b-3p;
miR-378f; miR-378i; mir-7641-1-p3; miR-27b; miR-133c; miR-1260b; miR-1260; miR-185; miR-708; miR-30b-3p; miR-7977; mir-5100-p5;
miR-5100; mir-708-p5; miR-4454; miR-486; miR-30c-1-3p; miR-150; mir-4454-p5; mir-5100-p3; miR-1386; mir-6240-p3; miR-345-5p;
mir-4454-p3; miR-193b; miR-22-3p; miR-1386; mir-2285 m-3-p5; miR-193a-3p; miR-486-5p; miR-22-5p; miR-497; mir-2285 k-3-p5;
miR-29a; miR-34
5 miR-543-3p; miR-3959-3p; miR-3958-3p; miR-154b; miR-154b-5p; miR-493-5p; miR-432; miR-485-3p; miR-380-3p; miR-324-5p;
miR-154a-3p; mir-324-p5; miR-379-3p; miR-382-5p; miR-411b-3p; miR-409-3p; miR-411a-3p; miR-379-5p; miR-487b-3p; miR-329a-3p;
miR-329b-3p; miR-15b; miR-127; mir-15b-p3; miR-15b-5p; miR-130a; miR-214; mir-376d-p3; miR-410
6 miR-542-3p; mir-2284f-p3; miR-322-5p; miR-376c-3p; miR-369-3p; miR-376d; miR-376e-3p; let-7a-p3; miR-424-5p; miR-218a;
miR-144-3p; miR-20a-5p; miR-21; miR-21a-5p; miR-374a; miR-19b; miR-301a; miR-450b; miR-499-3p; miR-208b
aAll species identifiers were removed. Fourteen anonymous probes beginning with the designation ‘PC’ were excluded, but can be found with species identifiers
in Additional file 1.b miRNA included in the targeted qRT-PCR investigatation highlighted in bold.
F91 F140 P5 173P F91 F140 P5 P173 F91 F140 P5 P173
Cluster 1 Cluster 2 Cluster 3
Cluster 4 Cluster 5 Cluster 6
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Fig. 5 k-means clustering of the differentially expressed miRNA. miRNA were grouped into co-expression clusters using k-means clustering.
A summary of non-redundant miRNA present in each k-means cluster can be found in Table 2. F Fetal, P Postnatal, d age in days
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miRNA) was used for mRNA target prediction using MiR-
Walk. The strategy undertaken was highly conservative as
MiRWalk was chosen to include a consensus of at least
seven of ten different miRNA target prediction methods
[42]. The numbers of unique target mRNAs for the six
miRNA clusters were 1050, 1034, 914, 963, 989 and 1292,
respectively. Enriched Gene Ontology (GO) terms and
KEGG pathways were then identified using DAVID [43]
(Fig. 7; FDR corrected P < 0.05 and limited to a maximum
of the five top ranked pathways). The full KEGG pathway
analysis and the enriched GO categories Biological
Process, Cellular Component and Molecular Function for
each cluster are listed in Additional file 2.
Cluster 1 was strongly associated with an extracellular
matrix theme in the enriched KEGG pathway and GO
Cellular Component (CC) analyses. There was also a
theme related to regulation of transcription revealed by
the GO Biological Process (BP) and Molecular Function
(MF) categories. KEGG pathway analysis for Cluster 2
showed enrichment for proliferative activity and insulin
signalling while regulation of transcription was a common
theme in the GO BP and MF analyses. GO BP showed
enrichment for aspects of macromolecule metabolism and
biosynthesis. Cluster 3 showed enrichment for protein
transport (GO BP) and synapse (GO CC), the latter
possibly indicative of innervation changes. Cluster 4
was associated with regulation of transcription (GO BP
and MF), regulation of biosynthetic processes (GO BP)
and neuron projection (GO CC). Enrichment for the
TGFβ pathway was linked with Cluster 5 as well as
regulation of phosphate metabolic processes (GO BP),
Golgi (GO CC) and regulation of transcription (GO MF).
Cluster 6 showed mixed themes including MAPK sig-
nalling and extracellular matrix (KEGG), regulation
of transcription (GO BP and MF) and Golgi (GO CC).
Importantly, Clusters 1, 2 and 6 contained enriched
pathways that have been associated with “cancer”, which
likely reflect aspects of cell proliferation, while Clusters
1, 2 and 4–6 contained enrichment for terms associated
with transcription factor regulation, which also may
reflect transcriptional regulation of cardiomyocyte pro-
liferative activity.
Discussion
This study is the first to analyse the expression of miRNA
in a mammalian model (sheep) where, as in humans, car-
diomyocyte quiescence occurs in utero. The current study
highlights species specific differences and some similarities
in the expression patterns of specific miRNA previously
implicated in the regulation of cardiomyocyte proliferation
and regeneration in rodents and zebrafish. The interpret-
ation of miRNA and target gene developmental profiles in
DLK1 MEG3
RTL1
RTL1AS
MEG8 DIO3MIRG
OAR18
BEGAIN
miR-493
miR-665
miR-431
miR-433
miR-127
miR-432
miR-136
miR-3955miR-370
50 kb
Fig. 6 Schematic representation of an imprinted genomic segment on the telomeric arm of ovine chromosome 18. The genomic region highlights
multiple miRNA many of which were identified as differentially expressed in Cluster 5. Blue, paternally expressed protein encoding genes. Pink,
maternally expressed noncoding RNA. The central region contains a number of maternally expressed miRNA including a large cluster designated MIRG.
MEG8 contains a large cluster of snoRNA while MEG3 is a long noncoding RNA. RTL1AS transcribes a noncoding RNA containing five miRNA, which are
known to cause RISC mediated cleavage of the sense protein encoding gene RTL1. All maternally expressed genes are transcribed in the same direction
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different species may be complex. First, the sheep and ro-
dent models of cardiac development are inherently differ-
ent in terms of the timing of cardiomyocyte quiescence
and moreover the latter models are potentially confounded
by superimposition of developmental changes with large
scale postnatal metabolic changes and cardiomyocyte
hypertrophy. Second, some miRNA target genes may vary
in the sequence of their potential miRNA recognition sites
leading to changes in the binding affinity and stoichiometry
of miRNA with target genes. This could generate altered
molecular processes regulating similar developmental pro-
cesses in a species specific manner. Third, changes in
miRNA abundance may impact other related miRNA
through direct competition for target mRNA. The use of a
miRNA microarray in combination with targeted analyses
in the sheep model has revealed enrichment for clusters of
miRNA belonging to functional categories possibly associ-
ated with cardiomyocyte proliferation/quiescence such as
‘proliferative activity’ and ‘cancer’ (which is characterised
by cell proliferation) and provided broad insight into the
program of cardiac development in a large mammal where
cardiomyocyte quiescence occurs during late gestation,
similar to human and unlike rodents and zebrafish.
Identification of miRNA with expression profiles consistent
with involvement in inhibition of cardiomyocyte
proliferation in sheep
Cardiomyocyte quiescence is observed in sheep from
0.75 of gestation [32] and only ~1 % of cardiomyocytes
are in the cell cycle near term [33]. miRNA that are key
inhibitors of cardiomyocyte proliferation would likely fall
predominantly into miRNA Cluster 4 or possibly 1 and
3, since their expression patterns increase with age.
Consistent with this view, miRNA implicated in rodent
cardiomyocyte quiescence, miR-133a, miR-497 and miR-
195, were identified in Clusters 4, 4 and 1, respectively,
from the miRNA microarray analysis. In particular, miR-
133a, the highly abundant cardiac miRNA implicated in
regulation of cardiomyocyte proliferation in zebrafish [7]
and mice [17], was confirmed by qRT-PCR and micro-
array analysis as increasing with developmental age in
sheep. The role of miR-133a as a suppressor of cardio-
myocyte proliferation is supported by both miR-133a
double-knockout (miR-133a-1/miR-133a-2) mouse studies
showing that miR-133a is essential for regulating cardio-
myocyte proliferation and normal heart development [17],
and zebrafish studies, where miR-133a was significantly
reduced in regenerative/proliferative cardiac tissue [7].
The increased abundance of miR-133a coincided with the
decreased expression of one of its gene targets, IGF1R.
The IGF1R signalling pathway is an important regulator of
cardiac development [25] and stimulates cardiomyocyte
proliferation [24]. The current investigation is the first to
highlight a potential link between miR-133a and IGF1R in
the regulation of cardiomyocyte proliferation in a large
mammal. However, the expression of other miR-133a tar-
get genes (identified in other species) that are pro-
proliferative [7, 17–20], either increased in postnatal life
(SRF, CCND2, PGAM1 and GJA1) or did not change
with age (CTGF) in the sheep. These observations sug-
gest that these genes are not target genes for miR-133a
in sheep or that there are additional contributors to
cardiomyocyte quiescence that counter the effects of
these pro-proliferative genes. Additional limitations
associated with cross species comparative analyses of
miRNA function are listed in the Methods section.
Although the miR-15 family has been implicated in regu-
lation of cardiomyocyte proliferation in rodents [12, 27],
there was remarkable variation in the expression
profiles for the family members, being represented in
Clusters 1, 2, 4 and 5. Since these family members have
highly similar target mRNA, it is difficult to interpret
the relevance of individual family members in regulat-
ing cardiomyocyte proliferation. One possibility is that
the different expression patterns represent fine tuning
of the ratio of this miRNA family to target mRNA at
different development ages. The expression profiles of
miR-15 family target mRNA (CHEK1, CDC2A, BIRC5
and SPAG5) were consistent with decreased cardio-
myocyte proliferation perhaps representing their spe-
cific roles in cell cycle regulation. The current findings
in sheep however suggest that the miR-15 family may
not be pivotal or direct regulators of the specific de-
crease in cardiomyocyte proliferation that occurs in late
gestation and in early postnatal life in sheep.
While the exact role of each miRNA in Cluster 4, 1
and 3 is yet to be defined, it is noteworthy that miR-145,
which has been implicated as an inhibitor of cell prolif-
eration by down-regulating IGF1R in bladder cancer
cells [44] and other cancers [45–47], was present in
Cluster 4. Further analysis into the functional role of
each miRNA identified in these clusters is required in
order to determine which miRNA have a role in devel-
opmental cardiomyocyte quiescence.
(See figure on previous page.)
Fig. 7 Representations of enriched KEGG pathways for predicted target genes associated with each k-means cluster. DAVID was used to identify
enriched KEGG pathways [43]. An FDR adjusted P-value <0.05 was considered significant. The top ranked five pathways are shown. Clusters 3 and
4 did not produce any significantly enriched KEGG pathways. Each cluster is identified by a number. FDR corrected P-values are shown on a –
log10 scale (significance cut-off >1.3). Full data for enriched KEGG pathways and the three GO categories Biological Process, Cellular Component
and Molecular Function are listed in Additional file 2
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Identification of miRNA that may promote cardiomyocyte
proliferation in sheep
In sheep, miRNA that have been previously identified as
key promoters of proliferation in rodents are predicted
to have decreased expression with age and therefore
reside in Clusters 2, 5 or 6. miR-199a, which has been
shown to stimulate proliferation in cultured rat cardio-
myocytes [13] was identified in Cluster 2, however,
further analysis using qRT-PCR demonstrated that miR-
199a peaked around birth, then decreased into postnatal
life to the level of that seen at 91 days gestation. Further-
more, the expression pattern of pro-proliferative miR-
590 [13] did not allow its inclusion in any cluster and
qRT-PCR demonstrated a similar expression at all ages.
Considering the varied expression of their target genes,
the outcomes of the present study suggest that miR-
199a and miR-590 are not major regulators of develop-
mental cardiomyocyte quiescence in sheep.
The roles of every miRNA in Clusters 2, 5 and 6 have
not been identified, however, some miRNA in these clus-
ters have been involved in aspects of the regulation of
cell proliferation in other species. Recent studies have
implicated the miR-17-92 group as an important regula-
tor of cardiomyocyte proliferation and capable of stimu-
lating previously quiescent, adult mice cardiomyocytes
[48]. There are six members of the miR-17-92 group,
which includes miR-17, miR-18a, miR-19a, miR-20a,
miR-19b-1 and miR-92a-1. In the present study, miR-17
and miR-92 were in Cluster 2 (increased with age),
which suggests a potential role of these miRNA in the
inhibition of cardiomyocyte proliferation in late gesta-
tion, however, miR-20a and miR-19b were in Cluster 6
(peaked before birth, but then decreased into postnatal
life) and the expression of miR-18a and 19a did not
change with age. Thus, the specific roles of miRNA in
the miR-17-92 group in regulating cardiomyocyte quies-
cence are unclear.
The developmental regulation of an imprinted miRNA
cluster during heart development
The present study has allowed us to isolate the period
when most cardiomyocytes lose the ability to proliferate
from other cellular processes, such as hypertrophy, that
are upregulated after birth. Cluster 5 was particularly
enriched for miRNA derived from an imprinted locus
located on the telomeric end of OAR18 in sheep (Fig. 6).
The syntenic region is conserved in placental mammals
and it contains a large cluster of maternally expressed
miRNA that may have complex roles in the cis- and
trans-regulation of expression of genes within the broader
imprinted ~1.1 Mb region or direct involvement in the
maintenance of the imprinting status of the locus [39, 40,
49, 50]. A mutation (Callipyge) in this broader imprinted
region in sheep strongly deregulates expression of multiple
genes within the core of this locus, including the mater-
nally expressed miRNA, and causes postnatal skeletal
muscle hypertrophy in select muscles in a rostro-caudal
gradient across the animal but only when the mutation is
inherited in the context of the paternal heterozygote [39].
The mutation apparently does not impact cardiac func-
tion, although specific tests have not been undertaken to
date. Whether the miRNA within this genomic locus are
targeted at mRNA or involved in imprinting maintenance
is not clear, but it is interesting to note that the miRNA
from this cluster putatively target the KEGG TGFβ path-
way. Multiple members of this pathway have strong roles
in regulating muscle development [51] and cardiac devel-
opment and disease [52, 53]. Maternally expressed genes
typically limit aspects of offspring tissue growth and are
often down-regulated after birth [54]. We therefore postu-
late that the down-regulation of these miRNA after birth
may help coordinate the activation of negative regulators
of growth thereby limiting cardiomyocyte size and possibly
heart size relative to body size.
Functional analysis of predicted targets of developmentally
regulated miRNA clusters
The functional enrichment analyses for the predicted
target genes for each miRNA cluster from the miRNA
microarray study often showed enrichment for “cancer”
related themes, which is likely indirectly reflecting prolif-
erative potential, and also enrichment for the related
terms transcription factor regulation and proliferative
activity. Thus, there is a consistent functional theme
relating to regulation of proliferation in the predicted
target genes of the differentially expressed miRNA. One
of the difficulties in the biological interpretation of
miRNA data relates to the abundance of a miRNA, its
mRNA targets and the effects of competing miRNA,
which together interplay in a complex manner to regu-
late gene expression. Therefore, understanding the
enriched biological themes in the current investigation
will require functional modulation of multiple miRNA in
an appropriate cell culture model of cardiomyocyte cell
proliferation and differentiation, coupled with biochem-
ical validation of putative miRNA target genes.
Conclusion
This study has identified miRNA and their target genes
associated with cardiac development across late gesta-
tion and into postnatal life in sheep, thereby isolating
the transition of cardiomyocytes to quiescence that
occurs in late gestation from the major physiological and
biochemical changes that occur after birth. The investi-
gation has identified a number of clusters of differen-
tially expressed miRNA, some of which are consistent in
timing with the suppression of cardiomyocyte proli-
feration, which occurs across the last third of gestation
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in sheep. The present study is also consistent with a
coordinated and complex role of miRNA in the regula-
tion of cardiomyocyte quiescence. The study identified
substantial differences between sheep and rodent cardiac
development that may reflect species differences under-
pinning the very different timing relative to birth of
cardiomyocyte quiescence in these species. Importantly,
through the use of miRNA microarrays, the current
study highlights the potential involvement of many
miRNA in the coordination of this pivotal developmen-
tal transition.
Methods
All experiments were performed according to guidelines
of both the University of Adelaide and the University of
South Australia Animal Ethics Committees.
Experimental protocol
Selection of gestational age groups
In sheep before 100 days gestation (term, 150 ± 3 d
gestation) all cardiomyocytes in the heart of the fetus are
mononucleated and capable of proliferation, thereafter
binucleation begins and hypertrophy becomes the pre-
dominant driver of cardiac growth [32, 33]. Therefore,
we chose for analysis a gestational age when all car-
diomyocytes were mononucleated (91 days; Fetal (F)90;
n = 6; Fig. 8), gestational ages when the proportion of
mononucleated cardiomyocytes will be decreasing (120
(F120) and 140 (F140) days; n = 8 and 6, respectively)
and after birth when the majority of cardiomyocytes are
quiescent, but undergoing metabolic maturation and
hypertrophy (5 (postnatal (P)5), 21 (P21) and 173 (P173)
days of age; n = 6, 6 and 9, respectively). For the expres-
sion of previously identified miRNA and target genes,
quantitative real-time RT-PCR (qRT-PCR) was per-
formed at each time point. For global miRNA expres-
sion, miRNA microarray analysis was performed using a
subset of three animals from each of the following time
points F91, F140, P5 and P173.
Tissue collection
For fetal time points (F21, F120 and F140), pregnant
ewes were humanely killed with an overdose of sodium
pentobarbitone (25 ml; 325 mg/mL; Virbac Aus,
Peakhurst, Australia) and fetuses were delivered by
hysterotomy, weighed and decapitated. For postnatal
time points (P5, P21 and P173), lambs were humanely
killed with an overdose of sodium pentobarbitone (as
above). The heart was dissected, weighed and a con-
sistent section of tissue from the free wall of the left
ventricle was flash frozen in liquid nitrogen and stored
at −80 °C for miRNA and mRNA analyses.
Extraction of miRNA and mRNA
Total RNA from the left ventricle (~50 mg) was ex-
tracted using the miRNeasy Mini Kit (QIAGEN Pty Ltd,
Doncaster, Australia). The miScript II RT Kit (QIAGEN
Pty Ltd, Doncaster, Australia) with the miScript HiFlex
Buffer was used to convert RNA into cDNA from 1 μg
of purified RNA [55].
Targeted measurement of miRNA and mRNA expression
using qRT-PCR
miRNA expression
cDNA was synthesised using miScript II RT kit (QIAGEN
Pty Ltd, Doncaster, Australia) following manufacturer’s in-
structions [55]. Controls containing no miScript II RT mix
(NAC) and no RNA transcript (NTC) were used to test for
genomic DNA and reagent contamination, respectively.
The reference miRNA (miR-26b, MS00009233; miR-92-
1, MS00006594 and SNORD61-1, MS00033705, QIAGEN
Pty Ltd, Doncaster, Australia)) were selected based on
expression analysis using the geNorm component of
the qBase relative quantification analysis software [56],
because their expression was stable across samples [57].
The relative expression of miR-133a (MS00031423,
QIAGEN Pty Ltd, Doncaster, Australia), the miR-15
family (miR-15a, MS00008785; miR-15b, MS00008799;
miR-16, MS00031493; miR-195, MS00008953; miR-
497, MS00031906; QIAGEN Pty Ltd, Doncaster, Australia),
miR-199a (MS00007602; QIAGEN Pty Ltd, Doncaster,
Australia) and miR-590 (MS00010269; QIAGEN Pty Ltd,
Doncaster, Australia) were measured using quantitative
real-time reverse transcription PCR (qRT-PCR) on an ABI
ViiA7 (PE Applied Biosystems, Foster City, CA). miScript
Primer Assays were used in conjunction with the miScript
SYBR Green PCR Kit (QIAGEN Pty Ltd, Doncaster,
Australia). Expression of each miRNA relative to the three
Fig. 8 Timing of cardiomyocyte maturation in sheep and experimental design. Fetal and postnatal time points corresponding to the transition of
cardiomyocytes from mononucleated and proliferative to quiescent and hypertrophic were chosen to analyse the expression of miRNA in the left
ventricle by either qRT-PCR (^) or miRNA microarray (*)
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stable reference miRNA was calculated using DataAssist
Software 3.0 (PE Applied Biosystems, Foster City, CA) [56]
and was expressed as mean normalised expression (MNE).
mRNA expression
cDNA was synthesized as previously described [58].
Controls containing no Superscript III (NAC) and no
RNA transcript (NTC) were used to test for genomic
DNA and reagent contamination, respectively.
The reference genes (ribosomal protein P0 [59], phos-
phoglycerate kinase 1 [60] and peptidylprolyl isomerase
A [60]) were chosen based on expression analysis using
the geNorm component of the qBase relative quantifica-
tion analysis software [56, 61], because their expression
was stable across samples [57]. The relative expression
of mRNA transcripts of miRNA targets and the reference
genes were measured by qRT-PCR using Fast SYBR®
Green Master Mix (Applied Biosystems, CA, USA) in a
final volume of 6 μL on a ViiA7 Fast Real-time PCR sys-
tem (Applied Biosystems), as previously described [57].
Primers (Additional file 3) were validated as generating
a single transcript and confirmed by the presence of one
double stranded DNA product of the correct size and
sequence. Controls containing no cDNA were included
for each primer set on each plate to test for reagent con-
tamination. Amplification efficiencies were determined
from the slope of a plot of Ct (defined as the threshold
cycle with the lowest significant increase in fluorescence)
against the log of the cDNA template concentration
(ranging from 1 to 100 ng). Expression of each transcript
relative to the three stable reference genes was calcu-
lated using DataAssist Software 3.0 and was expressed
as mean normalised expression (MNE).
Statistical analyses for miRNA and mRNA qRT-PCR
All data are presented as mean MNE ± SEM or as fold
change from expression at 91 days gestation. A proba-
bility value of 5 % (P <0.05) was considered significant.
Unless otherwise stated, comparisons between groups
were analyzed for statistical significance with a one-way
Analysis of Variance (ANOVA) followed by Duncans
Multiple Comparison post hoc tests, where appropriate,
using SPSS 20 for Windows (Statistical Package for
Social Scientists Inc., IL, USA).
miRNA microarray and data analysis
A custom designed miRNA microarray was employed
using a service provider (LC Sciences, USA). It con-
tained multiple (3–8) replicates of 3,098 unique probes
and multiple replicates (8–80) of 56 control probes. The
unique probes were derived from identified ovine miRNA
and additional mammalian miRNA sequences down-
loaded from miRBase (http://www.mirbase.org/). The
microarray included miRNA that have previously been
shown to be involved in cardiomyocyte proliferation
[7, 13, 27]. By its design the multispecies probe repre-
sentation on the microarray resulted in miRNA redun-
dancy. RNA, (2 μg) from three samples from each of the
F91, F141, P5 and P173 groups, was used for analysis
according to standard procedures (e.g. [62]). The experi-
mental design included three biological replicates from
each of the four developmental ages. Data were back-
ground corrected, log2 transformed and normalised
using a procedure in the commercial package CLCBIO
Genomics Workbench (http://www.clcbio.com/). ANOVA
analysis performed in CLCBIO identified differentially
expressed probes (FDR corrected P ≤ 0.05). Principal com-
ponents analysis was also undertaken using the same
package. Supplementary File 1 contains details of the dif-
ferentially expressed probes. The microarray dataset has
been deposited in the GEO database at NCBI (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68496).
k-means clusters
In k-means clustering, probes are clustered into k clus-
ters for which the distances between probes within a
cluster are small relative to the distance between clus-
ters. The differentially expressed probes from the micro-
array were subjected to k-means clustering in CLCBIO
using Euclidean distance and group means for the trans-
formed expressed values for each developmental age.
The difference between these values and the group mean
across all ages for each probe was then determined to
centre the data. A value of k = 6 was chosen as data
elimination (25 %) revealed profile stability while k
values greater than six did not produce substantially dif-
ferent profiles. Supplementary file 1 also contains cluster
designations for the significantly differentially expressed
probes.
miRNA target prediction and function analysis
A minimally redundant set of miRNA was derived from
the probes in each k-means cluster and filtered for
miRNA with mean expression across all samples less
than 100. 3p and 5p miRNA arms were ignored as they
cannot be used by most target prediction programs.
miRNA target prediction can involve high false positive
rates and hence conservative strategies are required.
Consequently, the miRNA in each cluster were used as in-
put into MiRWalk (http://www.umm.uni-heidelberg.de/
apps/zmf/mirwalk/) for target prediction. MiRWalk used a
consensus approach based on the intersection of at least
seven of ten different methods and utilised target infor-
mation from the human, rat and mouse genomes [42].
Redundant targets were then removed. Predicted targets
were assessed for Gene Ontology (GO) term enrich-
ments and KEGG pathway enrichments using DAVID
(http://david.abcc.ncifcrf.gov/) [43]. Only terms with
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FDR corrected P < 0.05 were used. EASE scores were set
at 0.05 to increase the analysis stringency.
Technical limitations of the study
To identify putative mRNA targets for the miRNA,
a nonredundant set of miRNA corresponding to each
k-means cluster was used for mRNA target prediction
using MiRWalk. This strategy used a consensus of at
least seven of ten different miRNA target prediction
methods [42]. Enriched Gene Ontology (GO) terms were
then identified using DAVID [43]. This conservative
approach has three inherent assumptions: (i) the pre-
dicted mRNA targets are expressed in the investigated
cardiac tissues; (ii) there is an inverse relationship be-
tween the direction of change in expression of a miRNA
and its target mRNA, and; (iii) stoichiometry (ratio of
abundance of miRNA to target) is not relevant.
There is a significant caveat when equating signal to
abundance in the miRNA microarray analysis. The
assumption is that the hybridization efficiency is con-
stant. This may be unlikely for all probes, especially as it
critically depends on GC content and probe length.
Although both the sheep and mouse miRNA data are
from miRNA microarrays using the same technologies,
there may be species differences that result in small dif-
ferences in sequence that affect hybridization. Further
confounding this area is the nature of the probes, which
in some cases relate to isomers.
Additional files
Additional file 1: Statistics for differentially expressed probes.
Additional file 2: DAVID KEGG pathway and GO functional
enrichments for mRNA targets predicted from miRNA representing
each k-means cluster.
Additional file 3: Primer sequences used in Quantitative Real-Time
Reverse Transcription-PCR.
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